RDTCF (Rapid Dose Therapeutics) Cyclically Adjusted Book per Share: $-0.01 (As of Nov. 2025)


RDTCF Rapid Dose Therapeutics Corp RDTCF
27 GF Score
Price $0.08
GF Value $0.30
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rapid Dose Therapeutics Cyclically Adjusted Book per Share?

Rapid Dose Therapeutics RDTCF -11.11% 27 Cyclically Adjusted Book per Share is $-0.01 as of Nov. 2025. GuruFocus rates RDTCF with a GF Score™ of 27/100 and a GF Value™ of $0.30 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Rapid Dose Therapeutics's adjusted book value per share for the three months ended in Nov. 2025 was $-0.035. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-0.01 for the trailing ten years ended in Nov. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Rapid Dose Therapeutics was -55.00% per year. The lowest was -55.00% per year. And the median was -55.00% per year.

As of today (2026-07-08), Rapid Dose Therapeutics's current stock price is $0.08. Rapid Dose Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Nov. 2025 was $-0.01. Rapid Dose Therapeutics's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Rapid Dose Therapeutics was 34.50. The lowest was 1.90. And the median was 4.92.


Rapid Dose Therapeutics  (OTCPK:RDTCF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Rapid Dose Therapeutics was 34.50. The lowest was 1.90. And the median was 4.92.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Rapid Dose Therapeutics Cyclically Adjusted Book per Share Related Terms


Rapid Dose Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics Cyclically Adjusted Book per Share Chart

Rapid Dose Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.01 0.00 0.00 -0.01

Rapid Dose Therapeutics Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.01

RDTCF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Rapid Dose Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Cyclically Adjusted PB Ratio falls into.


RDTCF
27GF Score
Rapid Dose Therapeutics Corp RDTCF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rapid Dose Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rapid Dose Therapeutics's adjusted Book Value per Share data for the three months ended in Nov. 2025 was:

Adj_Book= Book Value per Share /CPI of Nov. 2025 (Change)*Current CPI (Nov. 2025)
=-0.035/130.6821*130.6821
=-0.035

Current CPI (Nov. 2025) = 130.6821.

Rapid Dose Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.009 100.500 0.012
201509 -0.026 100.421 -0.034
201512 -0.018 99.947 -0.024
201603 -0.019 101.054 -0.025
201606 -0.022 102.002 -0.028
201609 -0.034 101.765 -0.044
201612 -0.003 101.449 -0.004
201703 -0.006 102.634 -0.008
201706 -0.010 103.029 -0.013
201709 -0.009 103.345 -0.011
201712 -0.016 103.345 -0.020
201809 0.010 105.636 0.012
201902 0.039 106.268 0.048
201905 0.030 107.927 0.036
201908 0.025 108.085 0.030
201911 0.008 107.769 0.010
202002 -0.001 108.559 -0.001
202005 -0.004 107.532 -0.005
202008 -0.008 108.243 -0.010
202011 -0.013 108.796 -0.016
202102 -0.011 109.745 -0.013
202105 0.028 111.404 0.033
202108 0.029 112.668 0.034
202111 0.027 113.932 0.031
202202 0.002 115.986 0.002
202205 -0.002 120.016 -0.002
202208 -0.007 120.569 -0.008
202211 -0.010 121.675 -0.011
202302 -0.019 122.070 -0.020
202305 -0.023 124.045 -0.024
202308 -0.027 125.389 -0.028
202311 -0.032 125.468 -0.033
202402 -0.020 125.468 -0.021
202405 -0.020 127.601 -0.020
202408 -0.022 127.838 -0.022
202411 -0.023 127.838 -0.024
202502 -0.028 128.786 -0.028
202505 -0.029 129.813 -0.029
202508 -0.032 130.208 -0.032
202511 -0.035 130.682 -0.035

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-0.01 mean?
Rapid Dose Therapeutics (RDTCF) has a Cyclically Adjusted Book per Share of $-0.01 as of Nov. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Rapid Dose Therapeutics and its competitors.
Is Rapid Dose Therapeutics' Cyclically Adjusted Book per Share too high?
Rapid Dose Therapeutics' current Cyclically Adjusted Book per Share is $-0.01. Overall, Rapid Dose Therapeutics has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Dose Therapeutics' Cyclically Adjusted Book per Share compare to VRTX and REGN?
Rapid Dose Therapeutics' Cyclically Adjusted Book per Share of $-0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current Cyclically Adjusted Book per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.30, compared to a current price of $0.08 — trading 73.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is $-0.01. Rapid Dose Therapeutics' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current Cyclically Adjusted Book per Share is $-0.01 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued. The current stock price of $0.08 is trading 73.3% below its estimated GF Value™ of $0.30. GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.

Key valuation signals for RDTCF:

  • Cyclically Adjusted Book per Share: $-0.01
  • GF Value™: $0.30 vs. price of $0.08 (73.3% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
27GF Score

Get the complete analysis for RDTCF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.30
GF Value